Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.360 | None | 1.000 | 1 | 0 | 1996 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.600 | None | 1.000 | 4 | 0 | 1997 | 2014 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 0 | 1998 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2017 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
group | 0.400 | None | 1.000 | 1 | 10 | 2007 | 2014 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
group | 0.330 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 1994 | 2015 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2010 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
group | 0.390 | None | 1.000 | 1 | 0 | 2002 | 2017 | ||||||||
|
suppressor of cytokine signaling 3 | 0.434 | 0.808 | 0.75 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
zinc finger E-box binding homeobox 1 | 0.442 | 0.808 | 0.97 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
AT-rich interaction domain 1A | 0.455 | 0.846 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
decorin | 0.457 | 0.808 | 0.31 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2012 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
group | 0.320 | None | 1.000 | 1 | 0 | 1999 | 2008 | ||||||||
|
F-box and WD repeat domain containing 7 | 0.465 | 0.808 | 1.00 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
group | 0.300 | None | 0 | 0 |